Abstract: The present disclosure provides: one or more salts or crystalline forms of 3-deuteromitragynine of Formula I; and one or more salts or crystalline forms of mitragynine of Formula II. Pharmaceutical compositions comprising salts and crystalline forms of Formulae I and II and methods of treatment are also disclosed. Methods of preparing and purifying the salts of Formulae I and II are further disclosed.